These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 7515265)

  • 1. Endogenous haemopoietic growth factors in neutropenia and infection.
    Cebon J; Layton JE; Maher D; Morstyn G
    Br J Haematol; 1994 Feb; 86(2):265-74. PubMed ID: 7515265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential alterations in plasma colony-stimulating factor concentrations in meningococcaemia.
    Waring PM; Presneill J; Maher DW; Layton JE; Cebon J; Waring LJ; Metcalf D
    Clin Exp Immunol; 1995 Dec; 102(3):501-6. PubMed ID: 8536364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulated plasma levels of colony-stimulating factors, interleukin-6 and interleukin-10 in patients with acute leukaemia and non-hodgkin's lymphoma undergoing cytoreductive chemotherapy.
    Reisbach G; Kamp T; Welzl G; Geiz C; Abedinpour Fariborz ; Lodri A; Kaboth W; Dörmer P; Nerl C
    Br J Haematol; 1996 Mar; 92(4):907-12. PubMed ID: 8616084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor levels in critical illness including sepsis and septic shock: relation to disease severity, multiple organ dysfunction, and mortality.
    Presneill JJ; Waring PM; Layton JE; Maher DW; Cebon J; Harley NS; Wilson JW; Cade JF
    Crit Care Med; 2000 Jul; 28(7):2344-54. PubMed ID: 10921563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) in serum during induction treatment of acute leukaemia.
    Sallerfors B; Olofsson T
    Br J Haematol; 1991 Jul; 78(3):343-51. PubMed ID: 1714757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O; Foss B; Petersen H
    Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adhesion molecules, endogenous granulocyte colony-stimulating factor levels and replating capacity of progenitors in autoimmune neutropenia of childhood.
    Perdikogianni Ch; Dimitriou H; Stiakaki E; Markaki EA; Kalmanti M
    Acta Paediatr; 2003 Nov; 92(11):1277-83. PubMed ID: 14696847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving treatment of chemotherapy-induced neutropenic fever by administration of colony-stimulating factors.
    Mayordomo JI; Rivera F; Díaz-Puente MT; Lianes P; Colomer R; López-Brea M; López E; Paz-Ares L; Hitt R; García-Ribas I
    J Natl Cancer Inst; 1995 Jun; 87(11):803-8. PubMed ID: 7540696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of G-CSF, M-CSF and GM-CSF in a patient with cyclic neutropenia.
    Misago M; Kikuchi M; Tsukada J; Hanamura T; Kamachi S; Eto S
    Eur J Haematol; 1991 May; 46(5):312-3. PubMed ID: 1710576
    [No Abstract]   [Full Text] [Related]  

  • 10. Recombinant human granulocyte-macrophage colony-stimulating factor therapy and endogenous plasma GM-CSF, IL-3, IL-4 concentrations in pediatric patients with solid tumors.
    Cetingül N; Kütükçüler N; Kantar M; Kavakli K; Nişli G; Cağlayan S; Oztop S
    Turk J Pediatr; 1997; 39(4):473-81. PubMed ID: 9433149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective randomized comparison of morning versus night daily single subcutaneous administration of granulocyte-macrophage-colony stimulating factor in patients with soft tissue or bone sarcoma.
    Dinçol D; Samur M; Pamir A; Sencan O; Akbulut H; Yalçin B; Onur H; Demirkazik A; Senler FC; Içli F
    Cancer; 2000 May; 88(9):2033-6. PubMed ID: 10813713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased levels of multiple forms of dihydrofolate reductase in peripheral blood leucocytes of cancer patients receiving haematopoietic colony-stimulating factors: interim analysis.
    Iqbal MP; Burney IA; Sultana F; Mehboobali N; Siddiqui T
    Exp Mol Med; 2000 Jun; 32(2):84-7. PubMed ID: 10926120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte-macrophage colony-stimulating factor in patients with neutropenic fever is potent after low-risk but not after high-risk neutropenic chemotherapy regimens: results of a randomized phase III trial.
    Ravaud A; Chevreau C; Cany L; Houyau P; Dohollou N; Roché H; Soubeyran P; Bonichon F; Mihura J; Eghbali H; Tabah I; Bui BN
    J Clin Oncol; 1998 Sep; 16(9):2930-6. PubMed ID: 9738560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte and granulocyte-macrophage colony-stimulating factors in cord and maternal serum at delivery.
    Bailie KE; Irvine AE; Bridges JM; McClure BG
    Pediatr Res; 1994 Feb; 35(2):164-8. PubMed ID: 7513077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circadian rhythm of granulocyte-macrophage colony-stimulating factor in normal subjects and neutropenic hospitalised patients.
    Abdelaal MA; Hashim IA; Zawawi TH; Felimban SK; Sobhi EM; Jeje O; Oni GA
    Ir J Med Sci; 2000; 169(1):55-7. PubMed ID: 10846861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic growth factors in colorectal cancer patients.
    Mroczko B; Szmitkowski M; Okulczyk B
    Clin Chem Lab Med; 2003 May; 41(5):646-51. PubMed ID: 12812262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of benefit of granulocyte macrophage or granulocyte colony stimulating factor in patients with febrile neutropenia.
    Siddiqui T; Burney IA; Kakepoto GN; Khurshid M; Salam A; Smego RA
    J Pak Med Assoc; 2002 May; 52(5):206-10. PubMed ID: 12174492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The plasma levels and diagnostic utility of selected hematopoietic growth factors (HGFs) in breast cancer patients].
    Ławicki S; Czygier M; Wojtukiewicz M; Szmitkowski M
    Przegl Lek; 2010; 67(12):1314-8. PubMed ID: 21591359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patients.
    Engel A; Mack E; Kern P; Kern WV
    Infection; 1998; 26(4):213-21. PubMed ID: 9717678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine concentrations are not predictive of bacteremia in febrile neutropenic patients.
    Buyukberber N; Buyukberber S; Sevinc A; Camci C
    Med Oncol; 2009; 26(1):55-61. PubMed ID: 18686048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.